News about our portfolio and insights from the vc world
Luna Begins Pivotal Trials for Automated Insulin Delivery
Luna, a Serpentine Ventures portfolio company, has started pivotal trials for its automated insulin delivery system, designed for the 90% of people who don't use insulin pumps. This innovation aims to improve glucose control.
Correntics Partners with Deloitte Switzerland for Climate Risk Solutions
Correntics, a Serpentine Ventures portfolio company, teams up with Deloitte to help companies identify and mitigate climate risks. This partnership combines scientific data with regulatory expertise to meet climate disclosure requirements.
Apaleo Reaches 1,500 Properties Across 30+ Countries
Apaleo, a Serpentine Ventures portfolio company, now serves over 1,500 properties worldwide with its open property management platform. Operating in 30+ countries, Apaleo is experiencing rapid growth across Europe, UK, US, and beyond.
Art Recognition Partners with Germann Auktionshaus
Art Recognition, a Serpentine Ventures portfolio company, has partnered with Germann Auktionshaus AG. Art Recognition’s AI authentication system will support Germann’s renowned art auctions, enhancing artwork provenance and authenticity.
Correntics Partners with UNIQA Sustainable Business Solutions
Correntics, a Serpentine Ventures portfolio company, is partnering with UNIQA to combine climate risk analysis with risk engineering and sustainability advisory, helping businesses enhance resilience and adapt to climate challenges.
Piomic Medical Wins Most Innovative Product Award at EPUAP 2024
Piomic Medical, a Serpentine Ventures portfolio company, has won the Most Innovative Product Award at EPUAP 2024 for its COMS One Therapy System. This recognition highlights their commitment to advancing pressure ulcer care for patients.